Nectin-4 ADC Drugs Market
According to a new report from Intel Market Research, the global Nectin-4 ADC Drugs market was valued at USD 1649 million in 2025 and is projected to reach USD 3090 million by 2034, growing at a robust CAGR of 9.3% during the forecast period (2025–2034). This growth is propelled by the increasing adoption of targeted therapies in oncology, rising prevalence of Nectin-4 overexpressing...
0 Σχόλια 0 Μοιράστηκε 96 Views 0 Προεπισκόπηση